‡a
Author's One percent tenofovir applied topically to humanized BLT mice and used according to the CAPRISA 004 experimental design demonstrates partial protection from vaginal HIV infection, validating the BLT model for evaluation of new microbicide candidates
‡a
1percenttenofovirappliedtopicallytohumanizedbltmiceandusedaccordingtothecaprisa004experimentaldesigndemonstratespartialprotectionfromvaginalhivinfectionvalidatingthebltmodelforevaluationofnewmicrobicidecandidates
‡A
One percent tenofovir applied topically to humanized BLT mice and used according to the CAPRISA 004 experimental design demonstrates partial protection from vaginal HIV infection, validating the BLT model for evaluation of new microbicide candidates
‡9
1